Evidence map›Paper›PMID 42064855›Full record

ArticleFrontiers in cardiovascular medicine2026

Prolonged

Zhuldyz Nurmykhametova, Rymbay Kaliyev, Timur Lesbekov, Linar Faizov, Assel Medressova, Aiym Turarova, Yerik Zuparov, Yuriy Pya

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhuldyz NurmykhametovaDepartment of Perfusiology and Assisted Circulation Laboratory, University Medical Center Corporate Fund, Astana, Kazakhstan.
Rymbay KaliyevDepartment of Perfusiology and Assisted Circulation Laboratory, University Medical Center Corporate Fund, Astana, Kazakhstan.
Timur LesbekovDepartment of Adult Cardiac Surgery, University Medical Center Corporate Fund, Astana, Kazakhstan.
Linar FaizovDepartment of Perfusiology and Assisted Circulation Laboratory, University Medical Center Corporate Fund, Astana, Kazakhstan.
Assel MedressovaDepartment of Adult Cardiac Surgery, University Medical Center Corporate Fund, Astana, Kazakhstan.
Aiym TurarovaDepartment of Anesthesiology, University Medical Center Corporate Fund, Astana, Kazakhstan.
Yerik ZuparovDepartment of Anesthesiology, University Medical Center Corporate Fund, Astana, Kazakhstan.
Yuriy PyaDepartment of Anesthesiology, University Medical Center Corporate Fund, Astana, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The safe ischemic window for static cold storage in heart transplantation is around 4-6 h, limiting donor retrieval distance and contributing to organ discard. We aim to assess whether a porcine heart preserved for 24 h using a novel ECMO-based ESHP system can maintain function after orthotopic transplantation. Five-orthotopic allogeneic heart transplantation were preserved for 24 h on a custom ECMO-based ESHP circuit at 37 °C, with coronary perfusion pressure 60-70 mmHg, and metabolic/hormonal supplementation. Hemodynamic, metabolic, and oxygenation parameters were measured using pulmonary arterial thermodilution via a Swan-Ganz catheter. Recipients were monitored for 4 h post-transplantation: cardiac output increased from 5.94 ± 0.16 L/min (baseline) to 6.78 ± 0.12 L/min (immediately post-transplant) (

Indexed as

ECMOex-situ heart perfusionheart transplantationnormothermic perfusionprolonged preservation

Identifiers

PMID42064855
PMCPMC13125029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.